ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2014

Survival outcome assessed according to tumor response and shrinkage pattern in patients with EGFR mutation-positive non-small-cell lung cancer treated with gefitinib or erlotinib.

Masayuki Takeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.